SkinCheck is a digital health startup dedicated to revolutionizing skin cancer detection and dermatological care access through innovative AI technology. Our platform offers a first-of-its-kind, racially unbiased AI-powered screening tool designed to detect skin cancer accurately across all skin tones. By empowering users with a mobile application for early risk assessment and streamlined teledermatology consultations, SkinCheck bridges the gap between patients and timely medical care. Our business model integrates both B2B and B2C channels, catering to individual users seeking accessible dermatological assessments, as well as health systems and providers aiming to enhance patient care and reduce costs through early detection. With over 130,000 users and partnerships with leading healthcare providers, SkinCheck is poised to transform skin health management globally by improving early detection and reducing healthcare inequities.
XomaHealth, LLC has developed an innovative, patented medical device to remedy Xerostomia (dry mouth), especially at night. This device will improve the quality of life for millions of patients.
Dry mouth causes loss of sleep, decline in dental health, loss of teeth, mouth sores, and other serious health issues. There are NO remedies for millions of people that have the significant medical problem of impaired or no saliva glands or for nighttime relief.
A study estimated 20% of the US population suffers from Xerostomia or approximately 66 million people. This demonstrates a significant market opportunity. XomaGuard will be an OTC product and there are no similar products on the market.
We are a fully packaged and customizable commercial fleet vehicle accident support platform. This means that when, for example, a fleet accident occurs, we align the process for the fleet drivers, fleet managers/companies, and any other party that may be involved. We provide real-time streaming of the accident process (what the fleet driver is doing after the accident) to the fleet company to ensure company protocol is being followed to the T. It is critical that there are no idiosyncrasies in the post-accident process to avoid many costly outcomes with litigation and claims issues being the most costly. We want to make sure that doesn’t happen to your fleet company.
Quillify aims to empower for-profit and nonprofit organizations alike with nondilutive funding to take their next step in productization through grants, government contracts, and public-private partnerships. Quillify developed this proven model by funding Quillify through the tools provided by Quillify. With advanced software applied to finding and writing these grants. Quillify reduces the associated labor costs by over 75%, saving weeks of time and effort, improving application quality, and ensuring project-grant alignment. Quillify additionally helps procurement offices in governments and foundations create these solicitation materials and manage incoming applications, reducing the time-to-acceptance, rework rates, and labor requirements by months. Quillify uses this ethical AI software to foster greater transparency and efficiency between public-private commercial partnerships and to bolster the innovation ecosystem at every level.
Register to attend March 2025 Pitch Lunch
